Medicinal Organic Cannabis Australia (MOCA)

Updates

Posted on Mar 11, 2021

MOCA announces its latest product range. CBD enriched SUPERFOOD pellets for horses. Full Spectrum using whole hemp plant and enriched with organic SUPERFOODS such as Spirulina and many others.

Learn more

Posted on Dec 16, 2020

Congratulations Medicinal Organic Cannabis Australia!

Following on from your recent nomination acceptance in the 2020 Commercial Cannabis Awards, the judging panel have made their final decisions and I am delighted to be the one to share the results with you.

The recent months have brought ab...

Posted on Sep 15, 2020

Join MOCA Director Alessandro Sorbello for a Facebook Live Q and A to learn about the companies activities and upcoming equity crowd campaign.

Learn more

Posted on Aug 26, 2020

MOCA is about to launch an equity crowdfunding campaign. If you are interested in investing in the medical cannabis industry, register your interest on this link to know more. Be quick.

Our Equity Crowd share Campaign will go live on the 21st of September, so stay tuned. Always consider the offe...

Learn more

Posted on Aug 26, 2020

MOCA is expanding and ready to import our new range of organic medical cannabis into Australia. This is a shout out to patients, medical practitioners, family and friends who are interested in investing via equity crowdfunding, register your expression of interest on this link.

Our Equity Crowd...

Posted on Jul 2, 2020

nvestors looking for a cannabis investment with less risk than the THC market have been snapping up hemp investments.

But with falling crop prices, regulatory uncertainty, and a pandemic that has put the brakes on retail sales, it’s become a foggy picture for investors.

It’s not all bad, howeve...

Learn more

Posted on Jun 9, 2020

Patient Registration to Visit with a Specialised Cannabis Medical Practitioner
The term 'medicinal cannabis products' covers a range of cannabis preparations intended for therapeutic use, including pharmaceutical cannabis preparations, such as oils, tinctures and other extracts.

In most states a...

Learn more

Posted on Jun 3, 2020

Organic CBD is now online

Learn more

Posted on Apr 2, 2020

Medical Cannabis Patient Intake Form

Wholesale medical cannabis supplier

Medicinal Organic Cannabis Australia (MOCA) Pty Ltd was founded in March 2017 and incorporated in June 2017. Australian State and Federal medical cannabis import, export and wholesale licences were awarded to MOCA in 2018. Directors, Alessandro Sorbello and Emanuela Ispani, founded the Company following changes to Australian legislation. The directors commenced with scientific research to develop MOCA’s product range. MOCA now has four PhD’s on the team and has converted its knowledge base to develop a product range of 21 organic medicines. Ten products developed by our scientific team under the MOCA brand and 11 products sourced from third party manufacturers, including CBDfx and Stanley Brothers. All our products are approved by the Australian Government (TGA) and can be prescribed by medical practitioners to treat a range of conditions including:

chronic pain
anxiety
chemotherapy-induced nausea and vomiting
epilepsy
palliative care indications
cancer pain
spasticity from neurological conditions
anorexia and other conditions.

The three key gateways to importing and supplying medical cannabis medicines by wholesale in Australia are:

State and Federal Government licenses to import and wholesale
Import permits from the Office of Drug Control (ODC)
Product approvals by the TGA

MOCA has all three gateways approved with licences, permits and approvals in hand.

Medicinal Organic Cannabis Australia (MOCA) is the first established organic cannabis company in Australia, with a focus on ethically sourced organic products.

Licenced: Australian import, export and wholesale licences for Medical Cannabis. European approvals and subsidies to cultivate in Europe
Products Approved: 21 products approved in Australia by the TGA
Import Permits: Australian import permits from the Office of Drug Control for all its products.
Products: has an approved range of MOCA branded organic cannabis products & has developed a new product that could reduce patient costs by 30%
Distribution: has supply agreements with pharmacies and practitioners in Australia.
Team: is science based with 4 PhD’s on the team to ensure product quality and standard. MOCA is focused on leveraging digital marketing channels. Has global third party warehousing and logistics suppliers in Australia.
International opportunities: were finalists in 2 international tenders to supply cannabis (Italy & Barbados)
Facilities: has a 15 year lease on a 18,000m2 cultivation facility in Italy with subsidised water and energy costs.

In conjunction with international standards, MOCA has developed proprietary production and manufacturing protocols and procedures. These operational methods of operation are approved at State and Federal level by the New South Wales Ministry of Health and the Office of Drug Control (ODC). They are designed to manage and meet its extensive regulatory compliance for the storage and handling of medical cannabis products.

These protocols mean that MOCA is ‘hands free’ and our entire process for transport, storage and distribution of our products are handled by Specialised global pharmaceutical contractors in their logistics centre.

This process eliminates the need for expensive proprietary warehousing costs and logistics staff, thus significantly reducing the Company’s operating costs to supply the products to medical professionals.

Medicinal Organic Cannabis Australia (MOCA) is committed to constantly engage with globally recognized research and development groups and manufacturers

Cannabis: the emerging face of well-being

Medicinal Organic Cannabis Australia (MOCA) is a fully licenced medical cannabis company specialized in wholesale importation and exportation of organic cannabinoids for Australian and New Zealand Markets. MOCA has strategic International partnerships which offer a proven, sustainable, stream of high quality products. We are supported by leading web based marketing platform to bring our products to Australian and international markets.

The company is informed by world class multinational best practices research. Medicinal Organic Cannabis Australian (MOCA) is offering opportunities for investing in the medical cannabis industry in Australia and New Zealand.

MOCA Activities at a glance:

Australian based company that commenced operations in March 2017 and was incorporated in June 2017. Its registered office is located at 903/50 Clarence Street, Sydney Australia

MOCA holds licences at State and Federal level to import and export S4 (CBD) and S8 (THC and CBD) products.

Mission Statement

To successfully supply approved businesses of all sizes with our high quality, ethically grown organic medical cannabis products.

Objective

MOCA’s primary objective is to become a leader in the Australian medical cannabis market. Our focus is on reducing patient access costs for medical cannabis products. We aim to educate medical practitioners, pharmacies and consumer markets on the health benefits of our products. The Company targets supplying the rapidly growing market in Australia with high quality organic cannabis medicine.

MOCA promotes our online sales division through internet marketing, and direct sales promotions to practitioners and pharmacists.

Our Responsibilities

Our first responsibility is to the doctors, nurses, and patients, to mothers and fathers and all others who will use our products and services.
Secondly, we are responsible to our employees who work with us throughout the world.
Thirdly, we are responsible to the communities in which we live and work and to the world community at large.
Our final responsibility is to our shareholders.

Our Approach to Manufacturing Products

We consider the ‘Triple Bottom line’ (People, Planet, Profit) the ethical measure of business. MOCA’s investment principle determines the impact on the environment, the social perspective, and our corporate governance.Whilst our current focus is on manufacturing and importing medical cannabis products, we are oriented on the entire ‘seed to sale’ process. At MOCA we believe that planting with appropriate organic practices can heal the soil and the earth and thus in turn, can heal its populace.

MOCA works with cultivators and purchases raw materials for manufacture, without intermediaries. It is for this reason that we influence and control the entire process from soil preparation to genetic selection to cultivation and harvest to manufacturing and wholesale.

Our aim is to offer a viable, affordable, plant based solution based on ethical practices. MOCA expands the traditional reporting framework to take into account social and environmental performance in addition to financial performance.

MOCA offers a wide range of organic medical cannabis products imported from the United States and Europe. The range of products includes organic capsules, oils, tinctures and cannabis flowers with THC, CBD and a combination of both. The Company is licensed to import, export and wholesale the full spectrum of medical cannabis products including THC and CBD products. Overall, MOCA meets the highly regulated medical cannabis needs of Australian regulators and International patients, medical doctors, pharmacies and hospitals.

Our CBD products are made from 100% organically grown, non-GMO Hemp. Cultivated premium grade, pesticide-free, heavy metal-free, solvent-free, gluten-free, THC-freeFDA-registered, cGMP-certified, ISO 9001, ISO 17025, industrial hemp registered, and 3rd-Party Tested.

MOCA holds permits from the Office of Drug Control to import our full range of 21 products including:

CBD Oil Capsules 750mg

Hemp and MCT Oil 500mg, 1000mg, 1500mg

CBD Flowers 5 grams, 10 grams, 28 grams

THC & CBD Flowers 10grams

MOCA CBD Capsules Full Spectrum 25mg

MOCA CBD DROPS 1000mg, 1500mg, 3500mg, 5000mg

MOCA CBD Isolates 99% and 99.88% CBD

Vape Pens 5ml

CBD Tinctures 60mg, 120mg, 300mg, 500mg

In order to ensure continuity of supply in potential times of limitations on product movement, we have multiple suppliers for each of our products. In the event of disruption in the supply chain, we are able to import our products, made to our specifications from different manufacturers